Skip to main content
Veterinary Medicines

P3-RHINOPLUS

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian paramyxovirus 3, strain PMV3, Inactivated

Product identification

Medicine name:
P3-RHINOPLUS
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
  • Newcastle disease virus, strain Ulster 2C, Inactivated
  • Avian paramyxovirus 3, strain PMV3, Inactivated
Target species:
  • Turkey
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Inactivated
    5.00
    log10 tissue culture infective dose 50
    /
    0.50
    millilitre(s)
  • Newcastle disease virus, strain Ulster 2C, Inactivated
    8.00
    log 10 50% embryo infective dose
    /
    0.50
    millilitre(s)
  • Avian paramyxovirus 3, strain PMV3, Inactivated
    6.70
    log 10 50% embryo infective dose
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CA02
Authorisation status:
  • Valid
Authorised in:
This information is not available for this product.
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A.
Responsible authority:
  • MdS
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 6/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."